Compare ASMB & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | CAL |
|---|---|---|
| Founded | 2005 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 400.3M |
| IPO Year | 2010 | 1994 |
| Metric | ASMB | CAL |
|---|---|---|
| Price | $28.40 | $10.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $43.40 | $14.00 |
| AVG Volume (30 Days) | 91.6K | ★ 457.7K |
| Earning Date | 01-01-0001 | 03-09-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $85,513,000.00 |
| Revenue This Year | $33.33 | $3.57 |
| Revenue Next Year | N/A | $4.11 |
| P/E Ratio | ★ N/A | $23.89 |
| Revenue Growth | N/A | ★ 0.46 |
| 52 Week Low | $7.76 | $9.54 |
| 52 Week High | $39.71 | $18.08 |
| Indicator | ASMB | CAL |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 34.04 |
| Support Level | $26.50 | $10.33 |
| Resistance Level | $31.11 | $13.55 |
| Average True Range (ATR) | 1.84 | 0.60 |
| MACD | 0.11 | -0.12 |
| Stochastic Oscillator | 57.55 | 8.28 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.